Suppr超能文献

[与新冠病毒免疫接种活动组织相关的风险映射]

[Risk mapping associated with organization of a COVID-19 immunization campaign].

作者信息

Le Tohic S, Basso S, Peillard L

机构信息

Département Pharmacie Biologie, Agence régionale de santé Provence-Alpes-Côte d'Azur, 132, boulevard de Paris, 13002 Marseille, France; Service de pharmacie hospitalière, Hôpital d'Instruction des Armées Laveran, 34, boulevard Laveran, 13013 Marseille, France.

Département Pharmacie Biologie, Agence régionale de santé Provence-Alpes-Côte d'Azur, 132, boulevard de Paris, 13002 Marseille, France.

出版信息

Ann Pharm Fr. 2022 Sep;80(5):697-710. doi: 10.1016/j.pharma.2022.01.006. Epub 2022 Jan 24.

Abstract

OBJECTIVES

COVID-19 caused more than 260,000 hospitalizations and nearly 64,000 deaths in France in 2020. Vaccination has become the best hope for gaining control of the pandemic. Our objective is to map the major risks associated with organization of the start of a COVID-19 immunization campaign in the Provence-Alpes-Côte d'Azur region, from December 2020 to April 2021 (inclusive).

MATERIALS AND METHODS

The process associated with organization of a COVID-19 immunization campaign was described. Risks, causes, consequences and control elements were identified by 14 semi-structured interviews, involving 19 professionals involved in the important stages in the process. The analysis was performed using the process approach and by a Failure Mode, Effects and Criticality Analysis (FMECA).

RESULTS

The process is divided into two approaches, one collective and one individual. Forty-seven risks have been identified and 15 actions proposed. Regional supply logistics chain, vaccination sites, appointment management and the Vaccine-COVID information system are the critical points. Overwork is the most common risk, which has been experienced by the study participants (n=18). It favours the disaffection of the health professionals, which is the major threat of this organization. Eligibility, medical consultation, and the post-vaccination period are under control.

CONCLUSIONS

Principal risks associated with organization of a COVID-19 immunization campaign have been identified and action plans have been proposed to optimize current and future practices. It gives a regional vision, to be compared with other regional, national, and international data.

摘要

目标

2020年,新型冠状病毒肺炎(COVID-19)在法国导致超过26万例住院病例和近6.4万例死亡。疫苗接种已成为控制疫情的最大希望。我们的目标是梳理出2020年12月至2021年4月(含)期间,在普罗旺斯-阿尔卑斯-蓝色海岸大区开展COVID-19免疫接种运动初期组织工作所涉及的主要风险。

材料与方法

描述了与COVID-19免疫接种运动组织工作相关的流程。通过14次半结构化访谈确定了风险、原因、后果及控制因素,访谈对象为参与该流程重要阶段的19名专业人员。分析采用流程方法及失效模式、影响及危害性分析(FMECA)。

结果

该流程分为集体和个体两种方式。已识别出47项风险并提出15项措施。区域供应物流链、接种点、预约管理及疫苗-COVID信息系统为关键点。工作过度是最常见的风险,参与研究的人员(n = 18)均有体会。这会导致卫生专业人员工作热情降低,而这是该组织面临的主要威胁。资格审查、医学咨询及接种后阶段处于可控状态。

结论

已识别出与COVID-19免疫接种运动组织工作相关的主要风险,并提出了行动计划以优化当前及未来的做法。本研究给出了一个区域视角,可与其他区域、国家及国际数据进行比较。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20f9/8785260/5e3c307f814c/gr1_lrg.jpg

相似文献

1
[Risk mapping associated with organization of a COVID-19 immunization campaign].
Ann Pharm Fr. 2022 Sep;80(5):697-710. doi: 10.1016/j.pharma.2022.01.006. Epub 2022 Jan 24.
4
An agent-based model to assess large-scale COVID-19 vaccination campaigns for the Italian territory: The case study of Lombardy region.
Comput Methods Programs Biomed. 2022 Sep;224:107029. doi: 10.1016/j.cmpb.2022.107029. Epub 2022 Jul 16.
5
Impact of the COVID-19 pandemic and the emergency measures on abortion care taken during this period in a French region (Provence Alpes Côte d'Azur).
J Gynecol Obstet Hum Reprod. 2022 Dec;51(10):102478. doi: 10.1016/j.jogoh.2022.102478. Epub 2022 Sep 13.
6
Sudden unexpected infant death characteristics in the French region of West Provence-Alpes-Côte d'Azur.
Paediatr Int Child Health. 2019 May;39(2):104-110. doi: 10.1080/20469047.2018.1533734. Epub 2018 Nov 1.
9
Impact of the SARS-CoV-2 pandemic on vaccine-preventable disease campaigns.
Int J Infect Dis. 2022 Jun;119:201-209. doi: 10.1016/j.ijid.2022.04.005. Epub 2022 Apr 6.
10
Measles outbreak response immunization during the COVID-19 pandemic: lessons from Borno State, Nigeria.
Pan Afr Med J. 2022 Feb 6;41:104. doi: 10.11604/pamj.2022.41.104.28162. eCollection 2022.

本文引用的文献

1
[Not Available].
Bull Acad Natl Med. 2021 Aug;205(7):671-672. doi: 10.1016/j.banm.2021.06.011. Epub 2021 Jun 8.
2
[Not Available].
Bull Acad Natl Med. 2021 Jun;205(6):551-552. doi: 10.1016/j.banm.2021.04.011. Epub 2021 Apr 18.
3
COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics.
Lancet Public Health. 2021 Apr;6(4):e210-e221. doi: 10.1016/S2468-2667(21)00012-8. Epub 2021 Feb 6.
4
[Not Available].
Bull Acad Natl Med. 2021 Feb;205(2):109-110. doi: 10.1016/j.banm.2020.12.018. Epub 2020 Dec 15.
5
[Not Available].
Bull Acad Natl Med. 2021 Mar;205(3):209-210. doi: 10.1016/j.banm.2021.01.011. Epub 2021 Jan 14.
7
Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review.
Vaccines (Basel). 2020 Dec 30;9(1):16. doi: 10.3390/vaccines9010016.
8
[COVID-19 and vaccination: a global disruption].
Med Sci (Paris). 2020 Nov;36(11):1034-1037. doi: 10.1051/medsci/2020203. Epub 2020 Nov 5.
10
Impact of COVID-19 on vaccination programs: adverse or positive?
Hum Vaccin Immunother. 2020 Nov 1;16(11):2594-2600. doi: 10.1080/21645515.2020.1787065. Epub 2020 Sep 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验